Lixte Biotechnology Holdings Inc (LIXT)
2.79
-0.17
(-5.74%)
USD |
NASDAQ |
May 07, 16:00
2.86
+0.07
(+2.51%)
After-Hours: 20:00
Lixte Biotechnology Holdings Cash from Operations (Quarterly): -0.9021M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.9021M |
| September 30, 2023 | -0.9444M |
| June 30, 2023 | -1.175M |
| March 31, 2023 | -1.271M |
| December 31, 2022 | -1.208M |
| September 30, 2022 | -1.174M |
| June 30, 2022 | -1.194M |
| March 31, 2022 | -1.035M |
| December 31, 2021 | -1.147M |
| September 30, 2021 | -0.9279M |
| June 30, 2021 | -1.042M |
| March 31, 2021 | -1.026M |
| December 31, 2020 | -0.739M |
| September 30, 2020 | -0.6237M |
| June 30, 2020 | -0.3546M |
| March 31, 2020 | -0.414M |
| December 31, 2019 | -0.3775M |
| September 30, 2019 | -0.5876M |
| June 30, 2019 | -0.3296M |
| March 31, 2019 | -0.3794M |
| December 31, 2018 | -0.5766M |
| September 30, 2018 | -0.1646M |
| June 30, 2018 | -0.272M |
| March 31, 2018 | -0.4977M |
| December 31, 2017 | -0.2843M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.4604M |
| June 30, 2017 | -0.3384M |
| March 31, 2017 | -0.329M |
| December 31, 2016 | -0.4698M |
| September 30, 2016 | -0.4801M |
| June 30, 2016 | -0.4016M |
| March 31, 2016 | -0.3259M |
| December 31, 2015 | -0.6123M |
| September 30, 2015 | -0.5089M |
| June 30, 2015 | -0.5213M |
| March 31, 2015 | -0.5386M |
| December 31, 2014 | -0.6444M |
| September 30, 2014 | -0.3378M |
| June 30, 2014 | -0.2937M |
| March 31, 2014 | -0.3596M |
| December 31, 2013 | -0.316M |
| September 30, 2013 | -0.2844M |
| June 30, 2013 | -0.2992M |
| March 31, 2013 | -0.2805M |
| December 31, 2012 | -0.2257M |
| September 30, 2012 | -0.2959M |
| June 30, 2012 | -0.4353M |
| March 31, 2012 | -0.249M |
| December 31, 2011 | -0.5656M |
| September 30, 2011 | -0.4042M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.271M
Minimum
Mar 2023
-0.3296M
Maximum
Jun 2019
-0.8671M
Average
-0.9444M
Median
Sep 2023
Cash from Operations (Quarterly) Benchmarks
| iBio Inc | -4.706M |
| PAVmed Inc | -11.87M |
| PDS Biotechnology Corp | -8.457M |
| Moleculin Biotech Inc | -5.407M |
| Syros Pharmaceuticals Inc | -18.56M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -4.293M |
| Free Cash Flow Per Share (Quarterly) | -0.4004 |
| Free Cash Flow Yield | -78.40% |